Global expansion of GBM AGILE: A phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract


Authors: Weller, M.; Berry, D.; Blondin, N.; Boulmay, B.; Buxton, M.; Chinot, O.; Colman, H.; de la Fuente, M.; de Groot, J.; Drappatz, J.; Ducray, F.; Ellingson, B.; Galldiks, N.; Gordon, G.; Hau, P.; Hottinger, A.; Hyddmark, V.; Khasraw, M.; Kim, L.; Lassman, A.; Lee, E.; Lim, M.; Mellinghoff, I.; Mikkelson, T.; Nghiemphu, P.; Perry, J.; Ronellenfitsch, M.; Sulman, E.; Tabatabai, G.; Tanner, K.; Touat, M.; Wen, P. Y.; Wick, A.; Yung, W.; Cloughesy, T.
Abstract Title: Global expansion of GBM AGILE: A phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Meeting Title: 19th Meeting of the European Association of Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 5
Meeting Dates: 2024 Oct 17-20
Meeting Location: Glasgow, United Kingdom
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-10-01
Start Page: v139
Language: English
ACCESSION: WOS:001340502000475
DOI: 10.1093/neuonc/noae144.473
PROVIDER: wos
Notes: Meeting Abstract: P27.11.A -- Abstract Citation ID: NOAE144.473 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors